These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 36379189)
1. Identification of molecular mechanisms underlying the therapeutic effects of Celosia Cristata on immunoglobulin nephropathy. Rehman A; Noor F; Fatima I; Qasim M; Liao M Comput Biol Med; 2022 Dec; 151(Pt A):106290. PubMed ID: 36379189 [TBL] [Abstract][Full Text] [Related]
2. Unraveling the Mechanism of Zhibaidihuang Decoction against IgA Nephropathy Using Network Pharmacology and Molecular Docking Analyses. Deng X; Luo Y; Lu M; Guan T; Li Y; Guo X Tohoku J Exp Med; 2022 Dec; 259(1):37-47. PubMed ID: 36288951 [TBL] [Abstract][Full Text] [Related]
3. Bioinformatics analysis reveals novel hub gene pathways associated with IgA nephropathy. Jiang X; Xu Z; Du Y; Chen H Eur J Med Res; 2020 Sep; 25(1):40. PubMed ID: 32894197 [TBL] [Abstract][Full Text] [Related]
4. Identification of key genes and pathways in IgA nephropathy using bioinformatics analysis. Hu SL; Wang D; Yuan FL; Lei QF; Zhang Y; Cheng JZ Medicine (Baltimore); 2020 Jul; 99(30):e21372. PubMed ID: 32791747 [TBL] [Abstract][Full Text] [Related]
5. Network Pharmacology and Experimental Validation to Explore That Celastrol Targeting PTEN is the Potential Mechanism of Zhao J; Liu H; Xia M; Chen Q; Wan L; Leng B; Tang C; Chen G; Liu Y; Zhang L; Liu H Drug Des Devel Ther; 2023; 17():887-900. PubMed ID: 36992900 [TBL] [Abstract][Full Text] [Related]
6. Construction of miRNA-mRNA network for the identification of key biological markers and their associated pathways in IgA nephropathy by employing the integrated bioinformatics analysis. Noor F; Saleem MH; Aslam MF; Ahmad A; Aslam S Saudi J Biol Sci; 2021 Sep; 28(9):4938-4945. PubMed ID: 34466069 [TBL] [Abstract][Full Text] [Related]
7. Understanding the molecular mechanism of the effect of ginkgo folium on the treatment of IgA nephropathy using network pharmacology and molecular docking. Ru X; Zhang Y; Gao Y; Wang H Nat Prod Res; 2022 Nov; 36(22):5836-5841. PubMed ID: 34927488 [TBL] [Abstract][Full Text] [Related]
8. Based on Network Pharmacology Tools to Investigate the Mechanism of Xia M; Liu D; Liu H; Zhao J; Tang C; Chen G; Liu Y; Liu H Front Med (Lausanne); 2021; 8():794962. PubMed ID: 34977095 [No Abstract] [Full Text] [Related]
9. Therapeutic effects of Basavarajappa GM; Rehman A; Shiroorkar PN; Sreeharsha N; Anwer MK; Aloufi B Front Pharmacol; 2023; 14():1187079. PubMed ID: 37180727 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic Mechanism of Xiaoqinglong Decoction against COVID-19 Based on Network Pharmacology and Molecular Docking Technology. Li HL; Zhou JP; Deng JM Comb Chem High Throughput Screen; 2022; 25(13):2264-2277. PubMed ID: 35227178 [TBL] [Abstract][Full Text] [Related]
11. Study on Betalains in Celosia cristata Linn. Callus Culture and Identification of New Malonylated Amaranthins. Lystvan K; Kumorkiewicz A; Szneler E; Wybraniec S J Agric Food Chem; 2018 Apr; 66(15):3870-3879. PubMed ID: 29597342 [TBL] [Abstract][Full Text] [Related]
12. Transmembrane signaling molecules play a key role in the pathogenesis of IgA nephropathy: a weighted gene co-expression network analysis study. Gholaminejad A; Roointan A; Gheisari Y BMC Immunol; 2021 Dec; 22(1):73. PubMed ID: 34861820 [TBL] [Abstract][Full Text] [Related]
13. Integrated System Pharmacology Approaches to Elucidate Multi-Target Mechanism of Khalid HR; Aamir M; Tabassum S; Alghamdi YS; Alzamami A; Ashfaq UA Molecules; 2022 Sep; 27(19):. PubMed ID: 36234758 [TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of aberrantly expressed profiles of mRNA and its relationship with serum galactose-deficient IgA1 level in IgA nephropathy. Liu Y; Liu X; Jia J; Zheng J; Yan T J Transl Med; 2019 Sep; 17(1):320. PubMed ID: 31547815 [TBL] [Abstract][Full Text] [Related]
15. Identification of Hub Genes and Therapeutic Agents for IgA Nephropathy Through Bioinformatics Analysis and Experimental Validation. Xia M; Liu D; Liu H; Peng L; Yang D; Tang C; Chen G; Liu Y; Liu H Front Med (Lausanne); 2022; 9():881322. PubMed ID: 35836957 [TBL] [Abstract][Full Text] [Related]
16. Exploring the Potential Mechanism of Shufeng Jiedu Capsule for Treating COVID-19 by Comprehensive Network Pharmacological Approaches and Molecular Docking Validation. Zhuang Z; Zhong X; Zhang H; Chen H; Huang B; Lin D; Wen J Comb Chem High Throughput Screen; 2021; 24(9):1377-1394. PubMed ID: 33135607 [TBL] [Abstract][Full Text] [Related]
17. Expression of CCL2, FOS, and JUN May Help to Distinguish Patients With IgA Nephropathy From Healthy Controls. Zhou X; Wang N; Zhang Y; Yu P Front Physiol; 2022; 13():840890. PubMed ID: 35464092 [TBL] [Abstract][Full Text] [Related]
18. Screening and Bioinformatics Analysis of IgA Nephropathy Gene Based on GEO Databases. Qian W; Xiaoyi W; Zi Y Biomed Res Int; 2019; 2019():8794013. PubMed ID: 31392215 [TBL] [Abstract][Full Text] [Related]
19. Identification and validation of glomerulotubular crosstalk genes mediating IgA nephropathy by integrated bioinformatics. Bai Y; Li Y; Xi Y; Ma C BMC Nephrol; 2022 Apr; 23(1):143. PubMed ID: 35418061 [TBL] [Abstract][Full Text] [Related]
20. Cytotoxic coumaronochromones from the inflorescences of Celosia cristata. Yan H; Zhang G Nat Prod Res; 2017 Aug; 31(16):1886-1890. PubMed ID: 27917658 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]